Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital

被引：23

作者：

Aljadani R. ^{[1
]}

Aseeri M. ^{[1
,2
]}

机构：

[1] Pharmacy Department, King Saud Bin AbdulAziz University for Health Sciences, King AbdulAziz Medical City, Riyadh

[2] Clinical Pharmacy Services, Pharmacy Department, King Saud Bin AbdulAziz University for Health Sciences, King AbdulAziz Medical City, PO Box 9515, Jeddah

来源：

BMC Research Notes | / 11卷 / 1期

关键词：

Ambulatory care; Drug-drug interactions; Geriatric; Pharmacy; Prevalence;

D O I：

10.1186/s13104-018-3342-5

中图分类号：

学科分类号：

摘要：

Objective: A cross-sectional study was performed from February to May 2015, to estimate the prevalence of drug-drug interactions in geriatric patients at the ambulatory care pharmacy at King Abdul-Aziz Medical City in Jeddah, Saudi Arabia. Results: A total of 310 patients were included, with a mean age (± SD) of 73.78 ± 6.96, and 48.70% were female. The overall prevalence of DDIs of all categories was 90.64%. Category B DDIs was 55.80%, category C DDIs 87.74%, category D DDIs 51.93%, and category X DDIs 16.45%. Atorvastatine plus omeprazole was identified as the most common interacting pair, with a prevalence of 25.26%. Multivariate logistic regression analysis showed that category D or X DDIs are more likely to occur in the female patient (OR = 1.79; 95% CI 1.07, 2.97), the patient taking more than three medications (OR = 22.62; 95% CI 2.93, 174.83), and the patient with more than two conditions (OR = 3.09; 95% CI 1.81, 5.27). © 2018 The Author(s).

引用

共 16 条

[1]

Astrand B., Astrand E., Antonov K., Petersson G., Detection of potential drug interactions - A model for a national pharmacy register, Eur J Clin Pharmacol, 62, pp. 749-756, (2006)

[2]

Peyriere H., Cassan S., Floutard E., Et al., Adverse drug events associated with hospital admission, Ann Pharmocother, 37, pp. 5-11, (2003)

[3]

Ferner R.E., Aronson J.K., Communicating information about drug safety, BMJ, 333, (2006)

[4]

Secoli S.R., Figueras A., Lebrao M.L., De Lima F.D., Santos J.L., Risk of potential drug-drug interactions among Brazilian elderly: A population-based, cross-sectional study, Drugs Aging, 27, pp. 759-770, (2010)

[5]

Bleich G.W., Bleich A., Chiamulera P., Et al., Frequency of potential interactions between drugs in medical prescriptions in a city in southern Brazil, Sao Paulo Med J, 127, pp. 206-210, (2009)

[6]

Cruciol-Souza J.M., Thomson J.C., A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital, Clinics (Sao Paulo), 61, pp. 515-520, (2006)

[7]

Silva N.M.O., Carvalho R.P., Bernardes A.C.A., Et al., Potential drug interaction evaluation in medical prescriptions in a public hospital specialized in women care, in Campinas, SP, Rev Ciênc Farm Básica Apl, 31, pp. 171-176, (2010)

[8]

Codagnone Neto V., Garcia V.P., Santa Helena E.T., Possible pharmacological interactions in hypertensive and/or diabetic elderly in family health units at Blumenau (SC), Braz J Pharm Sci, 46, pp. 795-804, (2010)

[9]

Janchawee B., Wongpoowarak W., Owatranporn T., Et al., Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand, J Clin Pharm Ther, 30, pp. 13-20, (2005)

[10]

Dinesh K.U., Subish P., Pranaya M., Et al., Pattern of potential drug-drug interactions in diabetic out-patients in a tertiary care teaching hospital in Nepal, Med J Malaysia, 62, pp. 294-298, (2007)

← 1 2 →